Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Finel

Showing results (231-240 of 248) with videos related to

Pageof 25
Sort By:
Leukemia|April 13, 2022
The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent yearsAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)S Dietrich, A Boumendil, H Finel, et al.
Transplantation and Cellular Therapy|December 28, 2022
Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for LymphomasAlberto Mussetti, Abraham S Kanate, Tao Wang, et al.
Nature Communications|August 30, 2024
Genome-wide analyses of neonatal jaundice reveal a marked departure from adult bilirubin metabolismPol Solé-Navais, Julius Juodakis, Karin Ytterberg, et al.
Leukemia|June 15, 2026
Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party studySimon Renders, Maud Ngoya, Laurence de Leval, et al.
Blood Advances|December 3, 2021
Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristicsMehdi Hamadani, Maud Ngoya, Anna Sureda, et al.
Cancer|October 24, 2018
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working PartyAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.
Blood Advances|February 7, 2019
PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCLPeter Dreger, Anna Sureda, Kwang Woo Ahn, et al.
British Journal of Haematology|July 10, 2018
High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMOIrit Avivi, Luca Arcaini, Virginia V Ferretti, et al.
Blood Cancer Discovery|February 6, 2025
Brexucabtagene Autoleucel versus Allogeneic Hematopoietic Cell Transplantation in Relapsed and Refractory Mantle Cell LymphomaNora Liebers, Ariane Boumendil, Hervé Finel, et al.
Pageof 25

Showing results (231-240 of 248) with videos related to

Sort By:
Pageof 25
Leukemia|April 13, 2022
The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent yearsAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)S Dietrich, A Boumendil, H Finel, et al.
Transplantation and Cellular Therapy|December 28, 2022
Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for LymphomasAlberto Mussetti, Abraham S Kanate, Tao Wang, et al.
Nature Communications|August 30, 2024
Genome-wide analyses of neonatal jaundice reveal a marked departure from adult bilirubin metabolismPol Solé-Navais, Julius Juodakis, Karin Ytterberg, et al.
Leukemia|June 15, 2026
Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party studySimon Renders, Maud Ngoya, Laurence de Leval, et al.
Blood Advances|December 3, 2021
Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristicsMehdi Hamadani, Maud Ngoya, Anna Sureda, et al.
Cancer|October 24, 2018
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working PartyAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.
Blood Advances|February 7, 2019
PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCLPeter Dreger, Anna Sureda, Kwang Woo Ahn, et al.
British Journal of Haematology|July 10, 2018
High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMOIrit Avivi, Luca Arcaini, Virginia V Ferretti, et al.
Blood Cancer Discovery|February 6, 2025
Brexucabtagene Autoleucel versus Allogeneic Hematopoietic Cell Transplantation in Relapsed and Refractory Mantle Cell LymphomaNora Liebers, Ariane Boumendil, Hervé Finel, et al.
Pageof 25